| Income Statement | 2025-09-30 | 2025-07-31 | 2024-10-31 | |
|---|---|---|---|---|
| Total other comprehensive (loss) income | 327 | -1,173 | 168 | |
| Comprehensive loss | -49,155 | -61,269 | -42,100 | |
| Earnings per share, basic | -0.92 | -1.12 | -0.91 | |
| Earnings per share, diluted | -0.92 | -1.12 | -0.91 | |
| Weighted average number of shares outstanding, basic | 53,883,681 | 53,497,128 | 46,695,220 | |
| Weighted average number of shares outstanding, diluted | 53,883,681 | 53,497,128 | 46,695,220 | |
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)